Document:

Exhibit 10.1

                                 PROMISSORY NOTE
                                 ---------------

$1,931,973.37                                                      July 15, 2005

      For value  received,  the  undersigned,  TASKER  CAPITAL  CORP.,  a Nevada
corporation (the "Company"), hereby promises to pay to the order of Indian River
Labs,  L.L.C.,  a Florida limited  liability  company (the "Holder"),  the total
principal  amount of ONE MILLION NINE HUNDRED  THIRTY-ONE  THOUSAND NINE HUNDRED
SEVENTY-THREE  DOLLARS AND  THIRTY-SEVEN  CENTS  ($1,931,973.37)  (the  "Loan"),
together with interest  thereon as set forth herein.  This Promissory Note (this
"Note")  will  mature and become due and  payable in full on July 20,  2007 (the
"Maturity Date").

      1. Terms of  Repayment.  Principal of and interest  upon this Note will be
paid by the Company as follows:

            (a) Interest.  This Note shall bear interest on the principal amount
outstanding  and unpaid  from time to time at a rate of 3.40% per annum,  simple
interest,  from the date  hereof  until the  Maturity  Date.  Interest  shall be
calculated on the basis of a 365-day year and paid for the actual number of days
elapsed.  Notwithstanding  any term contained herein,  the interest rate applied
herein  shall not exceed any such rate  required  by  applicable  usury or other
similar laws.

            (b) Payments.  The Company  promises to pay to the Holder  bi-weekly
principal and interest  payments in the amounts set forth on Schedule A attached
hereto.

            (c)  Prepayments.  The  Company  may prepay this Note at any time or
from time to time, in whole or in part.

            (d) Order of Payments. All payments will be applied first to accrued
interest, and then to principal.

      2. Events of Default.  Each and any of the  following  will  constitute  a
default and,  after  expiration  of a grace period,  if any, will  constitute an
"Event of Default" hereunder:

            (a) the  Company  shall  fail  to pay any  amount  of  principal  or
interest or other amount due hereunder (if any) within ten (10) calendar days of
the date on which such amount is due and payable hereunder; or

            (b) (i) the  Company  shall make an  assignment  for the  benefit of
creditors, or admit in writing its inability to pay or generally fail to pay its
debts as they  mature  or  become  due,  or  shall  petition  or  apply  for the
appointment  of a trustee or other  custodian,  liquidator  or  receiver  of the
Company or of any  substantial  part of its assets or shall commence any case or
other  proceeding  relating  to its  assets  under  bankruptcy,  reorganization,
arrangement,  insolvency,  readjustment  of debt,  dissolution or liquidation or
similar law of any  jurisdiction,  or shall take any action to  authorize  or in
furtherance of any of the foregoing;  or any such petition or application  shall
be filed or any such case or other  proceeding  shall be  commenced  against the
Company and the same shall not have been  dismissed  within sixty (60)  calendar
days of the filing or  commencement  thereof or the Company  shall  indicate its
approval  thereof,  consent  thereto or acquiescence  therein;  (ii) a decree or
order shall be entered  appointing  any such trustee,  custodian,  liquidator or
receiver or  adjudicating  the Company  bankrupt or  insolvent,  or  approving a
petition in any such case or other  proceeding,  or a decree or order for relief
shall be entered in respect of the Company in an involuntary case under any such
bankruptcy or insolvency  laws;  (iii) the  acceleration by any senior lender of
the Company from time to time (the "Senior Lender") of any indebtedness due from
the Company to the Senior Lender; or (iv) a Change in Control of the Company (as
defined below).

<PAGE>

            For purposes of this paragraph 2, "Change in Control" shall mean:

            (a) the  consummation  of a merger or  consolidation  of the Company
with or into another entity or any other corporate  reorganization involving the
Company,  if all or  substantially  all of the individuals and entities who were
the beneficial  owners of the outstanding  shares of Common Stock of the Company
immediately prior to such merger,  consolidation or other  reorganization do not
beneficially own,  directly or indirectly,  more than 50% of the combined voting
power of the continuing or surviving entity's securities outstanding immediately
after such merger,  consolidation or other  reorganization  in substantially the
same  proportions  as  their  ownership,   immediately  prior  to  such  merger,
consolidation or other reorganization, of the outstanding shares of Common Stock
of the Company;

            (b) the sale,  transfer or other disposition of all or substantially
all of the Company's assets;

            (c) a change in the  composition  of the Board of  Directors  of the
Company  (the  "Board")  , as a result of which  fewer  than  two-thirds  of the
incumbent  directors  are  directors  who either (i) had been  directors  of the
Company on the date 24 months prior to the date of the event that may constitute
a Change  in  Control  (the  "original  directors")  or (ii)  were  elected,  or
nominated for election,  to the Board with the  affirmative  votes of at least a
majority of the aggregate of the original  directors who were still in office at
the time of the  election or  nomination  and the  directors  whose  election or
nomination  was  previously so approved or (iii) satisfy any  combination of (i)
and (ii); or

            (d)  any  transaction  as a  result  of  which  any  person  is  the
"beneficial  owner" (as defined in Rule 13d-3 under the Securities  Exchange Act
of 1934, as amended (the "Exchange Act")), directly or indirectly, of securities
of the Company  representing at least 50% of the total voting power  represented
by the Company's then outstanding voting securities. For purposes of this clause
(d),  the term  "person"  shall have the same  meaning as when used in  Sections
13(d) and 14(d) of the  Exchange  Act but shall  exclude  (i) a trustee or other
fiduciary holding securities under an employee benefit plan of the Company or of
a parent or subsidiary of the Company and (ii) a corporation  owned  directly or
indirectly  by the  stockholders  of  the  Company  in  substantially  the  same
proportions as their ownership of the Common Stock of the Company.

                                       2
<PAGE>

      A transaction shall not constitute a Change in Control if its sole purpose
is to change  the state of the  Company's  incorporation  or to create a holding
company that will be owned in substantially  the same proportions by the persons
who held the Company's securities immediately before such transaction.

      3.  Holder's  Rights Upon  Default.  Upon the  occurrence  of any Event of
Default,  the Holder may (a)  accelerate  the  maturity  of this Note and demand
immediate  payment in full,  whereupon the outstanding  principal amount of this
Note and all  obligations  of the Company to the Holder,  together  with accrued
interest thereon and accrued fees and expenses (if any) payable on or in respect
of this Note,  will become  immediately  due and  payable to the Holder  without
presentment,  demand,  protest, notice of protest or further notice of any kind,
all of which are hereby  expressly  waived by the Company and (b)  exercise  all
legally available rights and privileges.

      4.  Costs  of  Enforcement.  Should  all or any  part of the  indebtedness
represented  by this  Note be  collected  by action  at law,  or in  bankruptcy,
insolvency,  receivership  or other  court  proceedings,  or should this Note be
placed in the hands of  attorneys  for  collection  after  default,  the Company
hereby promises to pay to the Holder,  upon demand by the Holder at any time, in
addition to the outstanding  principal  balance of, accrued interest and all (if
any) other  amounts  payable on or in respect of this Note,  all court costs and
reasonable attorneys' fees and other collection charges and expenses incurred or
sustained by the Holder.

      5.  Governing  Law.  This  Note  will  be  governed  by and  construed  in
accordance with the laws of the State of New York without regard to conflicts of
law principles and shall be enforceable only in courts of competent jurisdiction
in the State of New York.  The Company and the Holder  hereby  waive any and all
right to trial by jury in any civil action  arising out of, or based upon,  this
Note.

      6. Miscellaneous.

            (a) The Company  hereby  waives notice of  acceptance,  presentment,
notice of nonpayment,  protest, notice of protest, suit and all other conditions
precedent  in  connection  with  the  delivery,  acceptance,  collection  and/or
enforcement of this Note.

            (b) The rights  and  privileges  of the Holder  under this Note will
inure to the benefit of the Holder's successors and assigns.  All obligations of
the Company in connection with this Note will bind the Company's  successors and
assigns.

            (c) If any  provision of this Note will for any reason be held to be
invalid or unenforceable,  such invalidity or  unenforceability  will not affect
any other provision  hereof,  but this Note will be construed as if such invalid
or unenforceable provision had never been contained herein.

            (d) The waiver of any Event of Default or the  failure of the Holder
to exercise any right or remedy to which it may be entitled will not be deemed a
waiver of any subsequent Event of Default or the Holder's right to exercise that
or any  other  right or remedy to which  the  Holder  is  entitled.  No delay or
omission  by the Holder in  exercising,  or failure by the Holder to exercise on
any one or more occasions, any rights hereunder will be construed as a waiver or
novation  of this Note or prevent  the  subsequent  exercise  of any or all such
rights.

                                       3
<PAGE>

            (e) This Note may not be waived,  changed,  modified,  or discharged
orally,  but only in writing.  This Note may be waived,  changed,  modified,  or
discharged by an instrument signed by the Company and the Holder.

                  [remainder of page intentionally left blank]

                                       4
<PAGE>

      IN WITNESS WHEREOF, the undersigned has executed this Promissory Note as a
contract under seal as of the date first set forth above.

                                        TASKER CAPITAL CORP.

                                        By:_______________________________
                                           -------------------------------
                                        Name:
                                        Title:

                                       5Exhibit 10.2

                                                               EXECUTION VERSION

                   PATENT AND TECHNOLOGY SUB-LICENSE AGREEMENT

This  Agreement  is made as of July 15,  2005 by and among  PHARLO  IP,  LLC,  a
Florida limited liability company  ("Licensor"),  TASKER CAPITAL CORP., a Nevada
corporation  ("Tasker"),  and TASKER  PRODUCTS  IP  HOLDINGS  CORP.,  a Delaware
corporation and wholly-owned subsidiary of Tasker ("Tasker Products").

                                    RECITALS

A.    Pursuant to that certain  License  Agreement by and between  Barry Cummins
      ("Cummins")  and  Licensor,  dated July 15, 2005 and effective as of March
      18, 2005 (the "Base  License"),  Licensor is the exclusive  licensee under
      certain  Intellectual  Property  listed  and  described  on  the  attached
      Schedule A;

B.    Tasker  Products  and its  affiliates  desire to exploit the  Intellectual
      Property as set forth herein;

C.    Tasker has  previously  conveyed  consideration  to various  affiliates of
      Licensor in exchange for the right to exploit the Intellectual Property in
      certain Fields of Use;

D.    Licensor desires to grant a royalty free license to Tasker Products on the
      terms and  conditions  set forth herein to enable Tasker  Products and its
      affiliates to exploit the  Intellectual  Property in the Fields of Use and
      in the manner specified herein;

E.    Licensor  desires to get back a royalty free license from Tasker  Products
      under certain other  intellectual  property rights  identified  herein for
      uses outside the Fields of Use contemplated by this Agreement; and

F.    Licensor  desires to use Tasker as a licensed source of supply for certain
      products  to be used  outside  the Fields of Use in the  manner  specified
      herein.

      NOW, THEREFORE,  in consideration of the premises,  and for other good and
valuable  consideration,  the  receipt  of which is hereby  acknowledged  by the
Parties, the Parties hereto agree as follows:

                                    AGREEMENT

1.    Definitions.

      1.1   "Asset Purchase  Agreement"  shall mean an Asset Purchase  Agreement
            dated as of July 15,  2005 by and  among  Tasker,  Tasker  Products,
            Indian  River  Labs,  L.L.C.,   Pharlo  Citrus  Technologies,   Inc.
            ("PCTI"),  Pharlo Citrus Properties Partnership,  LLLP, and Coast to
            Coast Laboratories, LLC.

<PAGE>

      1.2   "Effective Time" shall mean the Effective Time which is specified in
            the Asset Purchase Agreement.

      1.3   "Field of Use" shall mean the fields of use set forth on  Schedule B
            attached hereto. ----------

      1.4   "Improvements" shall mean any additions, enhancements, improvements,
            or further  developments made by or on behalf of, or acquired by, or
            under the control of Licensor relating to the Technology on or after
            the Effective Time having application in the Field of Use.

      1.5   "Intellectual  Property"  shall  mean  the  Patents  and  Know  How,
            including without limitation that which is described on Schedule A.

      1.6   "Know  How"  shall  mean the  know  how,  trade  secrets  and  other
            proprietary  information now known to and hereafter  developed by or
            on behalf of  Licensor  relating to the  Technology  in the Field of
            Use.

      1.7   "Knowledge of the Licensor"  shall mean the actual  knowledge of any
            individual serving as an officer or manager of the Licensor.

      1.8   "Party"  or  "Parties"  shall  mean  Licensor,   Tasker  and  Tasker
            Products.

      1.9   "Patents" shall mean the patents and reissue  application  listed on
            Schedule A, and any patents  obtained by Licensor on an  Improvement
            in the Field of Use, whether or not listed on Schedule A.

      1.10  "PCTI Transferred  Patents" shall mean the patent applications which
            are  transferred  by PCTI to Tasker  Products  pursuant to the Asset
            Purchase  Agreement,  together with any patent resulting  therefrom,
            including  any   continuation,   continuation-in-part,   divisional,
            reexamination,  or reissue  that claim  subject  matter  outside the
            Field of Use.

      1.11  "Products" shall mean products,  compounds and devices embodying the
            Technology provided in the Field of Use.

      1.12  "Services"  shall mean services that embody the Technology  provided
            in the Field of Use.

      1.13  "Technology" shall mean a certain anti-microbial  compound disclosed
            and claimed in the Patents,  and methods,  processes,  and equipment
            for making and using such anti-microbial compound for end use in the
            Field of Use. In order to further clarify the  understanding  of the
            Parties  to  this  Agreement,  the  Technology  includes  by  way of
            example,  and without  limitation,  (i) a concentrate  which results
            from  the  combination  of an acid  with  an  ammonium  compound  in
            accordance with the manufacturing processes disclosed in the Patents
            ("Base Concentrate"),  and (ii) blends and end products derived from
            the Base Concentrate ("Derivative Products").

      1.14  "Territory" shall mean the world.

                                       2
<PAGE>

      1.15  "Third  Party  Transaction"  shall  mean  a  transaction   involving
            Licensor and an unaffiliated third party (other than Tasker,  Tasker
            Products or any of their affiliates)  pursuant to which the relevant
            third party would acquire rights under, in or related to the Patents
            outside the Field of Use.

      1.16  "Wynn Starr Agreement" shall mean the Exclusive Field of Use License
            Agreement and Product Sale  Agreement made effective as of September
            16, 2004,  as amended,  by and between  Tasker,  Wynn Starr  Special
            Products,  LLC,  PCTI,  Indian River Labs,  LLC and Licensor,  as in
            effect on the date hereof.

2.    Grant of License to Tasker Products.

      2.1   Licensor  hereby grants to Tasker  Products a royalty free exclusive
            (even as to  Licensor),  right and  license  under the  Intellectual
            Property  in the  Territory  to  import,  export,  make,  have made,
            manufacture,  use,  offer for sale and sell Products in the Field of
            Use and offer to provide and provide Services in the Field of Use.

      2.2   Tasker  Products  shall  have  the  unqualified  right,  at its sole
            discretion,  to sublicense and to assign to third parties all or any
            portion of the rights and licenses granted to it by Licensor in this
            Agreement. Such third parties include subsidiaries and affiliates of
            Tasker  Products as well as entities having no affiliation to Tasker
            Products.  All such assignees and  sublicensees  shall have the same
            rights and obligations as Tasker Products hereunder.

      2.3   Except  as  specifically  set forth in  Section  10  hereof,  Tasker
            Products has no other obligation to import, export, make, have made,
            manufacture,  use, offer for sale or sell  Products,  or to offer to
            provide or provide Services.

      2.4   Upon reasonable  request from Licensor,  Tasker Products will report
            to Licensor  regarding its activities with respect to its use of the
            Technology, Products or Services.

3.    Improvements.

      3.1   Licensor  agrees that all  Improvements  having  application  in the
            Field of Use made on or after the Effective Time shall become a part
            of  the  Intellectual   Property  and  shall  be  automatically  and
            immediately  licensed to Tasker Products  pursuant to this Agreement
            without further act or writing required.

      3.2   Licensor  agrees to disclose in writing all  Improvements  to Tasker
            Products  promptly  upon  discovery or  development  thereof in such
            full,  clear and complete terms as to enable Tasker Products to make
            and use the same in the Field of Use. Such disclosure  shall include
            without  limitation   conveying  to  Tasker  Products  any  and  all
            pertinent documentation and data in written and electronic form.

      3.3   None of Tasker or  Tasker  Products  shall  have any  obligation  to
            provide further  consideration,  payment or compensation of any kind
            to Licensor (or its  affiliates,  successors or assigns) in exchange
            for licensing Improvements as provided herein.

                                       3
<PAGE>

      3.4   All such  Improvements  shall be  entered by the  Parties  hereto on
            Schedule  A,  but it is  understood  that a  failure  to so  list an
            Improvement  shall not be construed to mean that such Improvement is
            not a part of  this  Agreement  and  not a part of the  Intellectual
            Property.

4.    Patents on Improvements.

      4.1   Licensor  shall have the right,  but not the  obligation,  to pursue
            timely patent  protection  for any and all  Improvements  within the
            Field of Use, in which case  Licensor  shall bear all costs and fees
            of prosecuting and maintaining such patent protection.

      4.2   Licensor  shall have  ninety  (90) days from the  development  of an
            Improvement in which to decide to pursue patent  protection for that
            Improvement.  In the event that Licensor elects not to pursue patent
            protection  for that  Improvement  in any  country or  jurisdiction,
            Licensor  shall notify  Tasker  Products  promptly in writing of its
            decision.

      4.3   Tasker  Products shall have the right,  but not the  obligation,  to
            pursue any patent on an Improvement  in any country or  jurisdiction
            upon being  notified  that Licensor has elected not to pursue patent
            protection  in such  country or  jurisdiction,  in which case Tasker
            Products  shall  bear  all  costs  and  fees  of   prosecuting   and
            maintaining such patent protection.

      4.4   Each Party shall provide  assistance and cooperation to the other to
            the extent necessary to prosecute and maintain patent  protection as
            provided  herein,   including  without   limitation   providing  the
            signatures   of  inventors   and   providing   necessary   data  and
            documentation.

5.    Right of First Refusal.

      5.1   If  Licensor,  from time to time desires to enter into a Third Party
            Transaction it shall first deliver to Tasker Products written notice
            of such intent  describing in detail the terms of the proposed Third
            Party Transaction ("Licensor's Notice").

      5.2   Tasker Products may, within fifteen (15) calendar days after receipt
            of any  Licensor's  Notice,  elect to enter into a transaction  with
            Licensor  for the same  consideration  and on the terms set forth in
            the Licensor's Notice. Such election shall be evidenced by a writing
            signed by Tasker  Products  and  delivered  to Licensor  within such
            fifteen  (15)  calendar  day  period  and shall be binding on Tasker
            Products.  A closing of the transaction  between Licensor and Tasker
            Products shall take place at a mutually  agreed location as promptly
            as is possible in the circumstances.

      5.3   In the event  that  Tasker  Products  does not elect to enter into a
            transaction  with Licensor on the terms of Licensor's  Notice within
            fifteen (15)  calendar days after Tasker  Products'  receipt of such
            Licensor's   Notice,   Licensor  may  enter  into  the  Third  Party
            Transaction  with the  applicable  third party free of the rights of
            first  refusal  set  forth  in this  Section  5 within  ninety  (90)
            ---------  calendar days after the expiration of such 15-day period,
            on terms no more  favorable to the third party  licensee  than those
            described  in the  Licensor's  Notice.  In the event  that the Third
            Party Transaction is not consummated  within such 90-day period, any
            subsequent attempt to enter into such a transaction shall be subject
            to this Section 5. ---------

                                       4
<PAGE>

6.    Research  and  Development  Assistance  to  Tasker  and  Tasker  Products.
      Licensor shall supply  research and  development  assistance to Tasker and
      Tasker Products pursuant to the following terms and conditions:

      6.1   Licensor  shall promptly  provide to Tasker and Tasker  Products all
            technical  assistance  reasonably able to be provided by Licensor to
            implement, refine and exploit the Intellectual Property in the Field
            of Use.

      6.2   Such  assistance  shall include such planning,  administration,  and
            management  of research and  development  activities in the Field of
            Use  as the  Parties  hereto  may  agree  upon  and  all  reasonably
            necessary   training,   documentation  and  data  that  Licensor  is
            reasonably able to provide.

      6.3   Such assistance shall also include  Licensor  promptly (but no later
            than ten (10) business days following a request by Tasker) providing
            qualified  personnel,  including  without  limitation David Creasey,
            Barry  Cummins,  and/or  David  Dickinson  (to the  extent  they are
            available)   to   facilities    designated   by   Tasker   ("On-Site
            Assistance"),  provided however that Licensor shall not be obligated
            to provide more than thirty (30) man-hours of On-Site  Assistance by
            its personnel in any calendar month pursuant to this Section 6.

      6.4   Tasker and Tasker  Products shall pay Licensor a fee ("R&D Fees") in
            quarterly   installments   commencing  at  the  Effective  Time  and
            terminating  upon  the  earlier  to  occur  of (a) the  later of the
            Termination  Date (as defined in Section 16  hereunder)  or the date
            this  Agreement is no longer in force or effect  pursuant to Section
            16 hereunder or, (b) the  termination of this Agreement  pursuant to
            Section  9.3  hereunder.  R&D Fees will be paid by Tasker and Tasker
            Products to Licensor in advance,  prior to the calendar  quarter for
            which they are payable. The R&D Fees will be as follows:
<TABLE>
<CAPTION>
--------------   ----------   ----------   ----------   ----------   ----------  -----------------
                  For 2005     For 2006     For 2007     For 2008     For 2009    For Calendar
                                                                                  Years after 2009
--------------   ----------   ----------   ----------   ----------   ----------   ----------------
<S>              <C>          <C>          <C>          <C>          <C>          <C>
First                  --     $   75,000   $  250,000   $1,000,000   $2,000,000   $2,000,000
Calendar
Quarter
--------------   ----------   ----------   ----------   ----------   ----------   ----------------
Second                 --     $   75,000   $  250,000   $1,000,000   $2,000,000   $2,000,000
Calendar
Quarter
--------------   ----------   ----------   ----------   ----------   ----------   ----------------
Third           $   25,000   $  100,000   $  500,000   $1,000,000   $2,000,000   $2,000,000
Calendar
Quarter
--------------   ----------   ----------   ----------   ----------   ----------   ----------------
Fourth           $   75,000   $  100,000   $  500,000   $1,000,000   $2,000,000   $2,000,000
Calendar
Quarter
--------------   ----------   ----------   ----------   ----------   ----------   ----------------
</TABLE>

      6.5   In addition,  Tasker and Tasker Products shall reimburse Licensor on
            a  monthly  basis  for  reasonable  travel  expenses  and any  other
            out-of-pocket  costs  associated  with  providing  the  research and
            development  assistance  pursuant  to this  Section  6,  subject  to
            Tasker's  reasonable  approval of Licensor's  substantiation  of the
            same.

                                       5
<PAGE>

7.    Infringement.

      7.1   In the event that any Patent is infringed by an  unauthorized  party
            and such  infringement  occurs  outside  the Field of Use,  Licensor
            shall have the right but not the  obligation  to enforce  its rights
            under that Patent,  including  without  limitation the bringing of a
            lawsuit for infringement of that Patent. In such event:

            (a)   Tasker  and  Tasker  Products  shall  cooperate  to the extent
                  reasonably  necessary,  including  without  limitation  making
                  records and personnel pertinent to the Patent, the Product and
                  the Intellectual Property available to Licensor.

            (b)   Licensor shall bear all costs and retain all monetary recovery
                  resulting from any such  litigation or other action to enforce
                  that Patent.

            (c)   Tasker  Products  shall  have  the  right  to  participate  in
                  negotiating  the terms of any settlement  reached in the event
                  that the settlement would affect the rights of Tasker Products
                  in the Field of Use.

      7.2   In the event that any Patent is infringed by an  unauthorized  party
            and  such  infringement  occurs  within  the  Field  of Use,  Tasker
            Products  shall have the right but not the obligation to enforce the
            rights of Licensor under that Patent,  including without  limitation
            the bringing of a lawsuit for  infringement of that Patent.  In such
            event:

            (a)   Licensor shall cooperate to the extent  reasonably  necessary,
                  including  without  limitation  allowing suit to be brought in
                  its  name,  making  records  and  personnel  pertinent  to the
                  Patent, the Product and the Intellectual Property available to
                  Tasker Products.

            (b)   Licensor may elect to participate in the  enforcement in which
                  case (i)  Licensor and Tasker  Products  shall share all costs
                  thereof  evenly  between  them and (ii)  Licensor  and  Tasker
                  Products shall divide all monetary recovery resulting from any
                  such  litigation  or other  action to enforce  that Patent (A)
                  first  so  that   Licensor  and  Tasker   Products  are  fully
                  reimbursed  for their  costs  and  expenses  relating  to such
                  litigation,  (B)  next,  from  any  remaining  amounts,  until
                  Licensor  and  Tasker  Products  recover  the  actual  damages
                  incurred by Licensor  and Tasker  Products as a result of such
                  infringement and (C) any remaining recovery to be split evenly
                  between Licensor and Tasker  Products.  If Licensor elects not
                  to participate in the enforcement,  then Tasker Products shall
                  bear all costs and retain all monetary recovery resulting from
                  any such litigation or other action to enforce that Patent.

            (c)   Licensor  shall have the right to  participate  in negotiating
                  the terms of any  settlement  reached  in the  event  that the
                  settlement  would  affect the rights of  Licensor  outside the
                  Field of Use.

      7.3   In the event that any Patent is infringed by an unauthorized  party,
            such infringement  occurs within the Field of Use and if and only if
            Tasker   Products   elects  not  to  take   action  to  enjoin  such
            infringement,  Tasker Products shall so notify Licensor and Licensor
            shall have the right but not the  obligation to enforce that Patent,
            including   without   limitation  the  bringing  of  a  lawsuit  for
            infringement of that Patent. In such event:

                                       6
<PAGE>

            (a)   Tasker  Products  shall  cooperate  to the  extent  reasonably
                  necessary,  including without  limitation  allowing suit to be
                  brought in its name, making records and personnel pertinent to
                  the  Patent,   the  Product  and  the  Intellectual   Property
                  available to Licensor.

            (b)   Licensor shall bear all costs and expenses of such litigation.

            (c)   Licensor  shall  receive all monetary  recovery  from any such
                  action or litigation.

            (d)   Licensor  shall  control all  aspects of any such  litigation,
                  except   that  Tasker   Products   shall  have  the  right  to
                  participate in negotiating the terms of any settlement reached
                  in the event that the  settlement  would  affect the rights of
                  Tasker Products in the Field of Use.

8.    Royalty.  The licenses  exchanged between  Licensor,  on the one hand, and
      Tasker or Tasker Products,  on the other hand,  hereunder are both royalty
      free.

9.    Cummins Base Patent License.

      9.1   The Parties  acknowledge and agree that (i) Licensor is obligated to
            make  certain  royalty  payments  to  Cummins  pursuant  to the Base
            License (the "Base License Royalty  Payments"),  (ii) that a failure
            by Licensor to make such Base License Royalty Payments can lead to a
            termination of the Base License, and (iii) that a termination of the
            Base License would materially adversely affect Tasker Products.

      9.2   Upon  delivery  by  Cummins of any notice to  Licensor  pursuant  to
            Section  3   ("Defaults")   of  the  Base  License,   Cummins  shall
            simultaneously deliver a copy of such notice to Tasker Products.

      9.3   Prior to any  termination  of the Base License,  (i) Licensor  shall
            assign (and Cummins shall consent to the assignment of) that portion
            of the Base License  representing  all of the rights  sublicensed to
            Tasker  Products  hereunder  (such that Tasker  Products  receives a
            direct license of all of its rights  hereunder  from  Cummins),  and
            (ii) thereafter, Tasker and Tasker Products shall pay to Cummins the
            royalties  provided to be paid by Licensor to Cummins under the Base
            License  (calculated  assuming this Agreement had remained in effect
            and that Licensor had received  from Tasker and Tasker  Products all
            amounts  required to be paid under  Sections 6 and 11 hereof).  Upon
            the  establishment  of the  direct  license  from  Cummins to Tasker
            Products  contemplated  herein, all of Tasker's and Tasker Products'
            obligations under this Agreement shall terminate, with the exception
            of Sections 7.1 - 7.3, 9.1 - 9.3,  12.1 - 12.2,  14.1,  15.1 - 15.4,
            17, and 18.1 - 18.8 hereunder.

                                       7
<PAGE>

10.   Supply Agreement.

      10.1  For a period of twelve months from this date of this  Agreement (the
            "Manufacturing Period"),  Tasker will supply Licensor with up to one
            hundred  gallons  per month of Base  Concentrate  and/or  Derivative
            Products  for use  outside  the Field of Use at no cost to  Licensor
            (other than costs  associated  with delivery).  To facilitate  this,
            Licensor, and to the extent necessary Tasker Products, hereby grants
            Tasker a worldwide non-exclusive royalty free license to manufacture
            Base  Concentrate and Derivative  Products solely for Licensor's use
            outside the Field of Use.

      10.2  From time to time during the  Manufacturing  Period , Licensor  will
            issue  purchase  orders  for  Base  Concentrate   and/or  Derivative
            Products setting forth specific  quantities  (subject to the monthly
            maximum set forth  above) and  indicating  the  location of delivery
            (which  may be  F.O.B  Tasker's  manufacturing  plant)  and  desired
            delivery  dates.  Licensor  shall issue orders in advance of desired
            delivery dates and Tasker shall use commercially  reasonable efforts
            to supply and ship the Base Concentrate  and/or Derivative  Products
            consistent  with such orders.  Licensor shall be responsible for all
            costs  associated  with  delivery  of the  Base  Concentrate  and/or
            Derivative Products.

      10.3  Nothing  herein  shall  restrict  Licensor's  rights to obtain  Base
            Concentrate  and/or  Derivative  Products from a supplier other than
            Tasker for use outside the Field of Use.

11.   Wynn Starr Agreement.

      11.1  Beginning  within  thirty  days after  December  31, 2005 and within
            thirty days after each March 31, June 30,  September 30 and December
            31 thereafter: (i) Licensor agrees to pay over to Tasker that amount
            of any royalties  which are actually  received by Licensor from Wynn
            Starr  pursuant to Section 4(c) of the Wynn Starr  Agreement  ("Wynn
            Starr  Royalties")  during the preceding  calendar quarter up to and
            not to exceed the amount of any R&D Fees actually paid by Tasker and
            Tasker Products to Licensor  pursuant to Section 6 hereunder  during
            that same preceding  calendar  quarter,  and (ii) to the extent that
            any Wynn Starr  Royalties  which are  actually  received by Licensor
            during the preceding  calendar  quarter exceed the R&D Fees actually
            paid by Tasker and Tasker Products to Licensor pursuant to Section 6
            hereunder  during that same  preceding  calendar  quarter,  Licensor
            agrees to pay over to Tasker  one-third  of the amount by which said
            Wynn Starr  Royalties  exceeded the R&D Fees actually paid by Tasker
            and Tasker  Products  to  Licensor  pursuant  to Section 6 hereunder
            during that same calendar quarter.

      11.2  Notwithstanding  the  provisions of Section 11.1, in the event that,
            Licensor ceases to receive  royalty  payments in respect of sales by
            Wynn Starr (or any affiliate thereof or successor to any thereof) of
            products  used in  post-harvesting  processing  aids for the poultry
            industry  based  on  technology   licensed  by  Licensor  to  Tasker
            Products,  Tasker  Products hereby agrees that it will pay, or cause
            to be paid, to Licensor  cash amounts  equal to the royalties  which
            Licensor is entitled to receive under Section 4(c) of the Wynn Starr
            Agreement with respect to such sales and which Licensor would not be
            required to pay over to Tasker pursuant to Section 11.1, and no such
            amount  shall be  required  to be paid  over to Tasker  pursuant  to
            Section 11.1.

                                       8
<PAGE>

12.   Grant Back of License Under PCTI Transferred Patents.

      12.1  Tasker   Products   hereby  grants  back  to  Licensor  a  worldwide
            exclusive,  even as to  Tasker  Products,  royalty-free,  right  and
            license to import, export, make, have made, manufacture,  use, offer
            for sale and sell any inventions  outside the Field of Use which are
            disclosed  and  claimed  in the  PCTI  Transferred  Patents.  Tasker
            Products disclaims all  representations  and warranties,  express or
            implied, with respect to such PCTI Transferred Patents.

      12.2  Subject to the limitations of Section 18.5 hereunder, Licensor shall
            have the right,  to sublicense and to assign to third parties all or
            any  portion  of the  rights  and  licenses  granted to it by Tasker
            Products in Section  12.1,  hereunder.  Such third  parties  include
            subsidiaries  and affiliates of Licensor as well as entities  having
            no  affiliation to Licensor.  All such  assignees and  sub-licensees
            shall have the same rights and obligations as Licensor hereunder.

13.   Warranties and Representations.

      13.1  Warranties and  Representations  of Licensor.  Licensor warrants and
            represents that:

            (a)   Licensor has the necessary limited liability company authority
                  and  authorization  to grant the  licenses as set forth herein
                  and to enter into this Agreement.

            (b)   The Patents are owned by Barry W. Cummins.  Licensor  holds an
                  exclusive  license under the Patents from Barry W. Cummins and
                  can  grant  the  licenses  set  forth  herein  under the terms
                  thereof.

            (c)   Except as provided herein,  there are no outstanding  options,
                  licenses, agreements, claims, encumbrances or shared ownership
                  of interests of any kind relating to the Intellectual Property
                  in the  Field of Use,  with the  exception  of the Wynn  Starr
                  Agreement.

            (d)   To the  Knowledge of the  Licensor,  the Patents are valid and
                  enforceable.

            (e)   Licensor makes no warranty or  representation  that the use of
                  the Intellectual Property by Tasker, Tasker Products or any of
                  their  affiliates  as  provided  herein  will not  infringe  a
                  patent,  or  similar  type  of  intellectual  property  in any
                  country, owned by, or claimed to be owned by, any third party.

            (f)   Licensor makes no warranty or  representation  that the use of
                  the Intellectual Property by Tasker, Tasker Products or any of
                  their  affiliates  as provided  herein does not  infringe  any
                  copyrights or trade secret rights of any third party.

                                       9
<PAGE>

      13.2  Warranty  and   Representation   of  Tasker.   Tasker  warrants  and
            represents  that  it  has  the  necessary  corporate  authority  and
            authorization to enter into this Agreement.

      13.3  Warranty and  Representation  of Tasker  Products.  Tasker  Products
            warrants  and  represents  that  it  has  the  necessary   corporate
            authority and authorization to enter into this Agreement.

14.   Indemnification.

      14.1  Tasker and Tasker Products,  jointly and severally, shall indemnify,
            defend  and  hold  Licensor,  its  affiliates,   members,  officers,
            employees  and agents  harmless from and against any and all claims,
            causes  of  action,  proceedings  and  litigation,  whether  or  not
            credible or well-founded,  that a Product or Service sold by Tasker,
            Tasker  Products or any of their  affiliates has violated a statute,
            regulation  or law of any  jurisdiction.  In  addition,  Tasker  and
            Tasker Products, jointly and severally, shall indemnify,  defend and
            hold Licensor,  its  affiliates,  members,  officers,  employees and
            agents  harmless  from and against any and all claims,  proceedings,
            causes  of  action  and  litigation,  whether  or  not  credible  or
            well-founded, that relate to or arise out of any allegation that:

            (a)   The use by Tasker,  Tasker Products or any of their affiliates
                  of the Intellectual Property infringes any claim of any patent
                  or similar  intellectual  property  in any  country  allegedly
                  owned by a third party; or

            (b)   The use by Tasker,  Tasker Products or any of their affiliates
                  of the Intellectual Property infringes any copyrights or trade
                  secret rights allegedly owned by any third party.

      14.2  Licensor shall indemnify,  defend and hold Tasker,  Tasker Products,
            and their  respective  affiliates,  officers,  employees  and agents
            harmless  from and  against  any and all  claims,  causes of action,
            proceedings and litigation, whether or not credible or well-founded,
            that a Base Concentrate or Derivative  Products made, used,  offered
            for sale,  sold,  imported,  or exported by Licensor  has violated a
            statute,  regulation  or  law  of  any  jurisdiction.  In  addition,
            Licensor shall indemnify,  defend and hold Tasker,  Tasker Products,
            and their  respective  affiliates,  officers,  employees  and agents
            harmless from and against any and all claims, proceedings, causes of
            action and litigation, whether or not credible or well-founded, that
            relate to or arise out of any allegation that:

            (a)   The use by Licensor of the Base  Concentrate or any Derivative
                  Products   infringes  any  claim  of  any  patent  or  similar
                  intellectual  property  in any  country  allegedly  owned by a
                  third party; or

            (b)   The use by  Licensor  of the Base  Concentrate  or  Derivative
                  Products  infringes  any  copyrights  or trade  secret  rights
                  allegedly owned by any third party.

15.   Confidentiality.  The  following  Confidentiality  provisions  shall apply
      during the term of this Agreement.

                                       10
<PAGE>

      15.1  Each Party may provide the other Parties with access to Confidential
            Information (as such term is defined in Section 15.2,  below).  Each
            Party understands and agrees that the Party providing  -------------
            such Confidential  Information (the "Providing Party") owns all such
            Confidential  Information  and that the  Providing  Party desires to
            protect the confidential and proprietary nature of that Confidential
            Information.  As a condition to  receiving  such  information,  each
            Party  agrees on behalf of itself and its  Representatives  (as such
            term is  defined  in  Section  15.3,  below) to  -------------  keep
            confidential  all  Confidential  Information  of the other  Parties.
            Except  as  contemplated  by the terms of this  Agreement,  no Party
            receiving  Confidential  Information  (the  "Receiving  Party") will
            copy,  distribute,  furnish or otherwise  disclose any  Confidential
            Information  of the  Providing  Party to any persons who are not the
            Receiving  Party's  Representatives  without  the  specific  written
            permission of the Providing Party.

      15.2  As used herein,  "Confidential  Information" means any and all trade
            secrets and other private,  confidential or proprietary  information
            that is  owned or  controlled  by the  Providing  Party  and/or  its
            customers or licensors and that has not been  publicly  disclosed or
            has not otherwise become common or public knowledge,  including such
            information  of third  parties in the  possession  of the  Providing
            Party  that the  Providing  Party is  under  an  obligation  to keep
            confidential.  Confidential  Information may be in intangible  form,
            such as unrecorded  knowledge,  ideas,  conceptions  or  information
            communicated orally or by visual observation,  or may be embodied in
            tangible form, such as documents, notes, memoranda,  reports, lists,
            records, drawings,  sketches,  formulae, models, training materials,
            specifications,   photographs,   graphic  representations  or  other
            information  recorded  or  communicated  by  electronic,   magnetic,
            optical or other media.

      15.3  Each  Party  agrees  that  now and at all  times in the  future  all
            Confidential  Information  shall be held in  strict  confidence  and
            disclosed only to those  directors,  officers,  members,  employees,
            agents,  affiliates,  advisors,  accountants  and  attorneys of such
            Party  (each of the  foregoing,  a  "Representative")  whose  duties
            reasonably  require access to such information,  and that each Party
            shall  use  Confidential  Information  only in  connection  with its
            performance   under  this   Agreement.   Each  Party  shall  protect
            Confidential  Information using the same degree of care, but no less
            than a reasonable  degree of care, to prevent the unauthorized  use,
            disclosure or duplication of such  Confidential  Information as such
            Party uses to protect its own confidential information. Confidential
            Information  shall be returned to the  Providing  Party or destroyed
            upon  the  Providing   Party's  request  upon  termination  of  this
            Agreement.

      15.4  No  Receiving  Party  shall  be  obligated   hereunder  to  hold  in
            confidence any Confidential Information of the Providing Party that:
            (i) is or becomes generally  available to the public other than as a
            result of disclosure by the Receiving Party or its Representative(s)
            in  breach  of  this   Agreement;   (ii)  the  Receiving  Party  can
            demonstrate was obtained by it from a non-confidential  source prior
            to the receipt of such  information  from the Providing Party or the
            Representative(s)   thereof;  (iii)  is  properly  received  by  the
            Receiving Party on a non-confidential basis from any third party who
            is  not  prohibited   from   transmitting   the   information  by  a
            contractual, legal or fiduciary obligation; (iv) the Providing Party
            agrees in  writing is free of  restrictions  on  disclosure;  (v) is
            independently  developed  by the  Receiving  Party or its  licensees
            without breach of this Agreement or (vi) is required to be disclosed
            by applicable law, judicial or other legally binding  administrative
            decree,  provided  that the Party so  required  shall (to the extent
            permitted by law),  provide advance notice to the Providing Party of
            such mandatory  disclosure and that the Providing  Party is given an
            opportunity to object to any such disclosure.

                                       11
<PAGE>

16.   Term.  This  Agreement  and the licenses  granted  herein shall  terminate
      automatically  on the expiration date of the last to expire of the Patents
      (the "Termination  Date").  However, in the event of the grant of a Patent
      Term  Extension of any  Patents,  this  Agreement  shall stay in force and
      effect after the Termination  Date only with respect to a product that was
      subject to a  regulatory  review  period  upon which any such  Patent Term
      Extension  was based,  but shall  otherwise  have no force and effect with
      respect to other products after the Termination Date.

17.   Notice. All notices,  requests,  claims,  demands and other communications
      hereunder  shall be in writing  and shall be given (and shall be deemed to
      have been duly given upon  receipt) by delivery  in person,  by  overnight
      courier or by facsimile (which is confirmed) to the respective  Parties at
      the following  address or fax number (or at such other address for a Party
      as shall be specified by like notice).

         If to Tasker or Tasker Products:   Chief Financial Officer
                                            Tasker Capital Corp.
                                            39 Old Ridgebury Road, Suite 14
                                            Danbury, CT  06810-5116
                                            Facsimile: 203.546.3427

         If to Licensor:                    Pharlo IP, LLC
                                            96 Willard Street
                                            Suite 101
                                            Cocoa, FL 32922
                                            Facsimile: 321.639.0488
                                            Attention:  David Dickinson

Such notices  shall be deemed to have been received five (5) business days after
mailing if forwarded by mail or on the day of receipt if delivered by hand.  The
address  of any Party may be changed  by giving  notice to the other  Parties in
accordance with the foregoing.

18.   Miscellaneous.

      18.1  Governing Law; Dispute Resolution.  This Agreement shall be governed
            by and  construed  in  accordance  with the law of the  state of New
            York, without regard to the conflict of laws principles thereof. All
            controversies  arising  from or  relating to this  Agreement  or the
            performance  or breach  thereof  shall be finally  resolved  through
            arbitration  in New York City,  New York,  under and  subject to the
            commercial Arbitration Rules of the American Arbitration Association
            ("AAA")  then in  effect,  and  shall be  conducted  in the  English
            language.  The  arbitration  shall be  before  a panel of three  (3)
            arbitrators, chosen according to the rules of the AAA from among its
            Panel of  Commercial  Arbitrators  within two (2) weeks of the first
            filing before the AAA, each of whom shall be and remain  independent
            of the Parties.  Licensor shall appoint one  arbitrator,  Tasker and
            Tasker Products shall appoint one arbitrator,  and the two appointed
            arbitrators  shall choose the third  arbitrator  who will act as the
            chairperson of the arbitration.  If the two arbitrators appointed by
            the  Parties  are not able to agree on the third  arbitrator  within
            thirty  (30)  calendar  days  from  the  date  that  the  last  such
            arbitrator was appointed, the third arbitrator shall be appointed by
            the AAA.

                                       12
<PAGE>

      18.2  Independent  Contractor.  The relationship between the Parties shall
            be that of independent contractors.  Nothing in this Agreement shall
            create,  or be deemed to imply the  creation  of,  any  partnership,
            joint  venture  or  other  relationship.  No  Party  shall  have the
            authority to incur any obligation,  contractual or otherwise, in the
            name or on behalf of another Party except as contemplated herein.

      18.3  Counterparts.  This  Agreement  may be  executed  by the  Parties in
            separate counterparts,  each of which when so executed and delivered
            shall be deemed to be an original,  but all such counterparts  shall
            together constitute one and the same instrument.

      18.4  Entire Agreement; Binding Effect. This Agreement, the Asset Purchase
            Agreement  and  the  documents  executed  in  connection  therewith,
            constitute  the  entire  agreement  between  the  Parties  as to the
            subject matter  contained herein and supersedes all other agreements
            between the Parties concerning such subject matter.

      18.5  Assignment;  No Third-Party  Beneficiaries.  This Agreement shall be
            binding on any  successors of the Parties.  Licensor  shall have the
            right to assign its interests in this Agreement (including the grant
            of sub-licenses by Licensor hereunder) to any other party who is not
            a competitor of Tasker within the Field of Use.  Licensor  shall not
            have the right to assign its interests in this Agreement  (including
            the grant of sub-licenses by Licensor  hereunder) to any other party
            who is a competitor  of Tasker  within the Field of Use,  unless the
            prior written consent of Tasker is obtained,  which consent will not
            be unreasonably withheld.  Tasker and Tasker Products shall have the
            right  to  assign  their  respective  interests  in  this  Agreement
            (including the grant of sub-licenses  by Tasker Products  hereunder)
            to any other party who is not a competitor  of Licensor  outside the
            Field of Use. None of Tasker or Tasker Products shall have the right
            to assign its interests in this  Agreement  (including  the grant of
            sub-licenses by Tasker Products hereunder) to any other party who is
            a competitor of Licensor  outside the Field of Use, unless the prior
            written  consent of Licensor is obtained,  which consent will not be
            unreasonably withheld.  This Agreement is not intended to, and shall
            not,  confer  upon anyone  other than the  Parties and their  lawful
            successors,  assigns,  and  sub-licensees  any  legal  or  equitable
            rights, benefits, claims or remedies of any nature.

      18.6  Amendment and Waiver. This Agreement shall not be modified except by
            a written  agreement  dated  subsequent  to the  Effective  Time and
            signed  on  behalf of the  Parties.  No waiver of any  breach of any
            provisions of this Agreement shall constitute a waiver of any prior,
            concurrent or subsequent  breach of the same or any other provisions
            hereof,  and no waiver shall be effective unless made in writing and
            signed by the Party to be charged.

                                       13
<PAGE>

      18.7  Severability.  If any term or other  provision of this  Agreement is
            held by a court of competent  jurisdiction  or other authority to be
            invalid,  illegal or incapable of being  enforced by any rule of law
            or  public  policy,  all other  conditions  and  provisions  of this
            Agreement shall nevertheless  remain in full force and effect.  Upon
            such  determination  by a court of competent  jurisdiction  or other
            authority  that any term or other  provision is invalid,  illegal or
            incapable of being  enforced,  the Parties  shall  negotiate in good
            faith to modify this  Agreement so as to effect the original  intent
            of the Parties as closely as possible in an acceptable manner to the
            end that the transactions  contemplated  hereby are fulfilled to the
            fullest extent possible.

      18.8  Termination of Agreement.  Without  limiting  Section 18.4, upon the
            Effective  Time,  all of  Tasker's  obligations  under  any  and all
            license  agreements with Licensor or PCTI (other than the Wynn Starr
            Agreement,   but  including  the  Exclusive  Field  of  Use  License
            Agreement  dated as of September 16, 2004, as amended,  by and among
            PCTI,   Licensor  and  Tasker  (the   "September  16,  2004  License
            Agreement") and the Exclusive  Field of Use License  Agreement dated
            as of September 20, 2004, as amended,  by and among PCTI,  Licensor,
            and Tasker (the  "September  20, 2004 License  Agreement"))  and all
            agreements  between  Licensor and any of its affiliates with respect
            to the subject  matter  hereof shall  terminate and be of no further
            force or effect,  except that (i) the sections of the  September 16,
            2004 License Agreement and Tasker's  obligations under the September
            16,  2004  License  Agreement  contemplated  to survive  termination
            thereof  in  Section  8.04  thereof,  will  remain in full force and
            effect,  and (ii) the  sections of the  September  20, 2004  License
            Agreement  and Tasker's  obligations  under the  September  20, 2004
            License  Agreement  contemplated to survive  termination  thereof in
            Section 8.04 thereof, will remain in full force and effect.

                           [Signature page to follow]

                                       14
<PAGE>

            IN WITNESS  WHEREOF,  the Parties have executed this Agreement as of
the date set forth above to be effective as of the Effective Time.

TASKER CAPITAL CORP.                        PHARLO IP, LLC

By ________________                                  By ___________________

Its ________________                                 Its ___________________

TASKER PRODUCTS IP HOLDING CORP.

By ________________

Its ________________

Acknowledged and agreed with respect to Sections 9.2 and 9.3 only:

-------------------------
Barry Cummins

Acknowledged and agreed with respect to Section 18.8 only:

Pharlo Citrus Technologies, Inc.

By:_______________________

Name:_____________________

Title:______________________

                                       15
<PAGE>

SCHEDULE A

1. U.S. No. 5,989,595

2. U.S. No. 6,242,011

3. Reissue application of 6,242,011

                                       16
<PAGE>

                                   SCHEDULE B

Field of Use

      1.    Pre-harvest  food  processing  and  safety  applications,  including
            treatment for plants and animals

      2.    Post-harvest  food  processing  and safety  applications,  including
            treatment for plants and animals, including the following:

      a.    antimicrobial  processing aide and food additive  including specific
            seafood applications, and

      b.    antimicrobial for airborne contaminants on cooked food

      3.    Breath and mouthwash applications

      4.    Hangover and alcohol abatement applications

      5.    Topical  palliative  for  dermatological  disorders,  including skin
            moisturizing   applications,   anti-wrinkle  applications  and  burn
            treatment applications

      6.    Pet product applications

      7.    Antimicrobial water treatment applications

                                       17

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00087-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00087-of-00352.parquet"}]]